Latest stories on HELP
Helus Pharma Fast-Tracks Phase 3 Enrollment for MDD Drug HLP003
TipRanks67 · bullishproduct/pr
HELP Stock Surges To Over 6-Month Highs Led By Crucial Phase 3 Milestone – Retail Expects It To Hit Fresh 52-Week Highs
Stocktwits News73 · bullishproduct/pr
A Depression Drug Just Cleared a Key Hurdle Early, and the Market for New Mental Health Treatments Keeps Widening
PR Newswire67 · bullishproduct/pr
Is Cybin D/B/A Helus Pharma (HELP) Stock a Psychedelic Medicine Opportunity Ahead of HLP003 Trial Results?
Yahoo Finance56 · neutralanalyst
Helus Pharma: APPROACHing Inflection: Pivotal Readout Sets Up Asymmetric Upside
Seeking Alpha63 · neutralanalyst
Helus Pharma Reports Recent Business Highlights and Fiscal Year 2026 Financial Results | HELP Stock News
StockTitan38 · neutralearnings
Cybin: A Speculative Bet On Their Pivotal Depression Readout
Seeking Alpha58 · neutralanalyst
A Breakthrough-Designated Depression Drug Is 86% Through Its Phase 3, With Topline Data Due This Year
PR Newswire67 · bullishproduct/pr
Helus Pharma Raises US$50 Million to Advance Late-Stage Mental Health Drug Pipeline
TipRanks58 · neutralgeneral
Helus Pharma™ Announces Closing of US$50 Million Underwritten Offering | HELP Stock News
StockTitan24 · bearishgeneral
Helus Pharma prices $50M public offering at $4.85 per share
Seeking Alpha26 · bearishgeneral
Helus Pharma™ Announces US$50 Million Underwritten Offering | HELP Stock News
StockTitan28 · bearishgeneral
Helus Pharma Provides Update on APPROACH Phase 3 Trial Enrollment Progress | HELP Stock News
StockTitan56 · neutralproduct/pr
Helus Pharma to Participate in the H.C. Wainwright 7th Annual Neuro Perspectives Conference | HELP Stock News
StockTitan55 · neutralproduct/pr
Helus Pharma to Participate in the Jefferies Global Healthcare Conference in New York | HELP Stock News
StockTitan56 · neutralproduct/pr